Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from ocean study

被引：0
|
作者：
Eastell, R. [1 ]
Nagase, S. [2 ]
Boonen, S. [3 ]
Spector, T. [4 ]
Small, M. [2 ]
Kuwayama, T. [2 ]
Sawyer, J. [5 ]
Deacon, S. [2 ]
机构：
[1] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
[2] Ono Pharma UK Ltd, Clin Dev, London, England
[3] Katholieke Univ Leuven, Leuven, Belgium
[4] Kings Coll London, London WC2R 2LS, England
[5] Prism Biodev Ltd, Nantwich, Cheshire, England
来源：
BONE | 2011年 / 48卷
关键词：
D O I：
10.1016/j.bone.2011.03.131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S92 / S93
页数：2
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 737 - 738
  • [32] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Kavanaugh, Arthur
    Puig, Luis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3324
  • [33] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Naomi Hayase
    Mariko Yamada
    Shuhei Kaneko
    Yoko Watanabe
    Clinical and Experimental Nephrology, 2021, 25 : 660 - 673
  • [34] Long-Term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: 2-year results from the NEURO-TTR open-label extension study
    Brannagan, T.
    Waddington Cruz, M.
    Wang, A. K.
    Polydefkis, M. J.
    Dyck, P. J.
    Khella, S.
    Plante-Bordeneuve, V.
    Berk, J. L.
    Barroso, F.
    Merlini, G.
    Conceicao, I.
    Hughes, S. G.
    Kwoh, J.
    Jung, S. W.
    Guthrie, S.
    Pollock, M.
    Benson, M. D.
    Gertz, M.
    Coelho, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 92 - 92
  • [35] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-year Results From a Phase 3, Multicenter, Double-blind, Placebo-controlled Study
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    SWISS MEDICAL WEEKLY, 2014, 144 : 8S - 9S
  • [36] LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    MacDiarmid, Scott
    Nicandro, J. P.
    Cheng, Maria
    Abrams, Steven
    Fein, Seymour
    Wein, Alan
    JOURNAL OF UROLOGY, 2017, 197 (04): : E398 - E398
  • [37] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Hayase, Naomi
    Yamada, Mariko
    Kaneko, Shuhei
    Watanabe, Yoko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 660 - 673
  • [38] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, P. J.
    Setty, A.
    Papp, K.
    Van den Bosch, F.
    Tsuji, S.
    Keiserman, M.
    Bu, X.
    Chen, L.
    Mccaskill, R.
    Mcdearmon-Blondell, E.
    Wung, P.
    Tillett, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 836 - 837
  • [39] Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma
    Dreyling, Martin H.
    Santoro, Armando
    Leppa, Sirpa
    Demeter, Judit
    Follows, George
    Lenz, Georg
    Kim, Won Seog
    Mollica, Luigina
    Nagler, Arnon
    Diong, Colin Phipps
    Provencio, Mariano
    Magagnoli, Massimo
    Radinoff, Atanas
    Munoz, Javier
    Cao, Anjun
    Hiemeyer, Florian
    Odongo, Fatuma
    Garcia-Vargas, Jose E.
    Childs, Barrett H.
    Zinzani, Pier Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY
    Mease, Philip J.
    Setty, Arathi
    Papp, Kim
    Van den Bosch, Filip
    Tsuji, Shigeyoshi
    Keiserman, Mauro
    Bu, Xianwei
    Chen, Liang
    Mccaskill, Reva
    Mcdearmon-Blondell, Erin
    Wung, Peter
    Tillett, William
    RHEUMATOLOGY, 2023, 62
12345